Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) has published newspaper advertisements regarding a Notice of Postal Ballot. The advertisements were published on December 24, 2025, in the Business Standard (English Daily) and Navshakti (Marathi Daily). The notice seeks approval from the company's members for a resolution concerning the appointment of Mr. Himanshu Agarwal (DIN: 06672915) as a Whole-time Director of the Company. This resolution requires an ordinary resolution. Members are informed that the Postal Ballot Notice, dated December 19, 2025, was sent electronically to eligible members whose email addresses were registered as of the cut-off date, December 19, 2025. The electronic dispatch of the notice was completed on December 23, 2025. The company is providing members with the facility to vote exclusively through electronic means (e-voting). The e-voting period will commence at 9:00 a.m. (IST) on Wednesday, December 24, 2025, and will conclude at 5:00 p.m. (IST) on Thursday, January 22, 2026. The e-voting module will be disabled thereafter. The results of the e-voting are expected to be announced on or before Friday, January 23, 2026, and will be published on the company's website (www.cohance.com), the KFinTech website (https://evoting.kfintech.com/), and communicated to the stock exchanges.